Company intelligence / Profile preview

Phytanix Bio

Santa Barbara, California, United Statesphytanix.com ↗
Ownership
Private
Development stage
Preclinical
01

Overview

Phytanix Bio is a preclinical-stage pharmaceutical company developing innovative medicines based on cannabinoids and cannabinoid-like compounds. The company leverages deep expertise from former GW Pharmaceuticals leadership to build a pipeline addressing serious unmet needs such as treatment-resistant facial seizures and Painful Bladder Syndrome. No clinical results have been reported yet; all programs remain in preclinical development.[1][2][5]

Therapeutic areas
NephrologyNeurology
Modalities
Small moleculeCannabinoid-based drugChemically synthesized modified-stilbenoid “hybrid” moleculesNanoparticle (via nano-formulation technology for improved delivery)
Industry
Biotech
02

Drug pipeline

2 assets

PHYX-001

Preclinical

1 more asset in the full pipeline.

Request access →
03

Partnerships

Exclusive license agreement with Nano4M Ltd for nano-formulation technologies to improve bioavailability of cannabinoids/cannabinoids-like drugs

Beyond the preview

Go deeper on Phytanix Bio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Phytanix Bio.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call